Alerts will be sent to your verified email
Verify EmailIMEC
IMEC Services
|
Binny Mills
|
Novelix Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
3671.03 % | 2.38 % | -17.5 % |
5yr average Equity Multiplier
|
0.25 | -1.02 | 1.26 |
5yr Average Asset Turnover Ratio
|
1.06 | 0.04 | 0.84 |
5yr Avg Net Profit Margin
|
849.61 % | -67.35 % | -14.11 % |
Price to Book
|
37.29 | 0.0 | 7.92 |
P/E
|
0.2 | 0.0 | 100.98 |
5yr Avg Cash Conversion Cycle
|
-733.28 Days | 15.76 Days | 29.1 Days |
Inventory Days
|
81.03 Days | 84.09 Days | 34.04 Days |
Days Receivable
|
43.33 Days | 20.05 Days | 55.38 Days |
Days Payable
|
787.7 Days | 129.33 Days | 55.7 Days |
5yr Average Interest Coverage Ratio
|
7.47 | 0.6 | -17.77 |
5yr Avg ROCE
|
6.01 % | -152.87 % | -15.4 % |
5yr Avg Operating Profit Margin
|
-68.78 % | 5.31 % | -16.49 % |
5 yr average Debt to Equity
|
-0.54 | -0.82 | 0.05 |
5yr CAGR Net Profit
|
n/a | n/a | 35.78 % |
5yr Average Return on Assets
|
2035.64 % | -3.02 % | -13.36 % |
Shareholdings
|
|||
Promoter Holding
|
30.3 % | 68.97 % | 52.75 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.15 % | -5.89 % | -14.17 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
IMEC Services
|
Binny Mills
|
Novelix Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|